| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 90 | 2024 | 707 | 13.200 |
Why?
|
| Cyclophilin A | 28 | 2024 | 36 | 5.300 |
Why?
|
| Virus Replication | 39 | 2024 | 304 | 4.520 |
Why?
|
| Carrier Proteins | 37 | 2020 | 710 | 4.490 |
Why?
|
| RNA, Viral | 17 | 2024 | 265 | 3.100 |
Why?
|
| Gene Products, gag | 31 | 2019 | 65 | 3.000 |
Why?
|
| Virion | 30 | 2021 | 117 | 2.990 |
Why?
|
| HIV Infections | 24 | 2024 | 919 | 2.950 |
Why?
|
| Immunity, Innate | 13 | 2024 | 766 | 2.880 |
Why?
|
| Capsid Proteins | 13 | 2024 | 94 | 2.670 |
Why?
|
| Capsid | 16 | 2024 | 88 | 2.580 |
Why?
|
| Dendritic Cells | 14 | 2024 | 509 | 2.320 |
Why?
|
| Tripartite Motif Proteins | 24 | 2024 | 39 | 2.320 |
Why?
|
| Ubiquitin-Protein Ligases | 26 | 2024 | 209 | 2.310 |
Why?
|
| Proviruses | 5 | 2024 | 25 | 2.270 |
Why?
|
| Retroviridae | 11 | 2021 | 73 | 1.940 |
Why?
|
| Host-Pathogen Interactions | 9 | 2023 | 239 | 1.700 |
Why?
|
| Ebolavirus | 7 | 2023 | 34 | 1.670 |
Why?
|
| Viral Regulatory and Accessory Proteins | 6 | 2018 | 22 | 1.650 |
Why?
|
| Viral Envelope Proteins | 5 | 2023 | 107 | 1.600 |
Why?
|
| Cyclosporine | 15 | 2024 | 56 | 1.590 |
Why?
|
| Cell Line | 38 | 2023 | 2014 | 1.590 |
Why?
|
| Amino Acid Isomerases | 11 | 1997 | 11 | 1.450 |
Why?
|
| Antiviral Agents | 6 | 2020 | 314 | 1.410 |
Why?
|
| Endogenous Retroviruses | 2 | 2024 | 9 | 1.380 |
Why?
|
| Cytokines | 5 | 2023 | 906 | 1.370 |
Why?
|
| Virus Integration | 6 | 2024 | 32 | 1.350 |
Why?
|
| Humans | 134 | 2024 | 59328 | 1.270 |
Why?
|
| Leukemia Virus, Murine | 8 | 2021 | 31 | 1.210 |
Why?
|
| Gene Products, vpr | 5 | 2018 | 8 | 1.180 |
Why?
|
| Anti-HIV Agents | 3 | 2018 | 153 | 1.180 |
Why?
|
| HeLa Cells | 24 | 2020 | 527 | 1.150 |
Why?
|
| beta Karyopherins | 3 | 2013 | 6 | 1.140 |
Why?
|
| Virus Assembly | 10 | 2020 | 53 | 1.100 |
Why?
|
| Transduction, Genetic | 6 | 2015 | 233 | 1.090 |
Why?
|
| HEK293 Cells | 15 | 2024 | 577 | 1.070 |
Why?
|
| Animals | 61 | 2024 | 19612 | 0.990 |
Why?
|
| Hemorrhagic Fever, Ebola | 3 | 2023 | 24 | 0.990 |
Why?
|
| Cell Nucleus | 8 | 2023 | 603 | 0.960 |
Why?
|
| Spike Glycoprotein, Coronavirus | 4 | 2023 | 97 | 0.960 |
Why?
|
| Introns | 2 | 2024 | 106 | 0.940 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2024 | 15 | 0.930 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2023 | 609 | 0.930 |
Why?
|
| Molecular Sequence Data | 33 | 2015 | 1977 | 0.890 |
Why?
|
| Argonaute Proteins | 1 | 2024 | 129 | 0.870 |
Why?
|
| Lymphocytes | 2 | 2023 | 194 | 0.840 |
Why?
|
| Simian Immunodeficiency Virus | 7 | 2015 | 79 | 0.840 |
Why?
|
| RNA, Small Interfering | 4 | 2024 | 851 | 0.840 |
Why?
|
| Killer Cells, Natural | 2 | 2023 | 214 | 0.820 |
Why?
|
| Lymphopenia | 1 | 2022 | 35 | 0.800 |
Why?
|
| DNA, Complementary | 4 | 2014 | 166 | 0.790 |
Why?
|
| Proteins | 9 | 2018 | 742 | 0.770 |
Why?
|
| HIV-2 | 5 | 2015 | 23 | 0.770 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 15 | 0.760 |
Why?
|
| Protein Binding | 25 | 2024 | 1550 | 0.750 |
Why?
|
| Recombinant Fusion Proteins | 14 | 2009 | 502 | 0.750 |
Why?
|
| Reverse Transcription | 4 | 2024 | 7 | 0.730 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2020 | 7 | 0.730 |
Why?
|
| Carbazoles | 1 | 2020 | 13 | 0.730 |
Why?
|
| Carbamates | 1 | 2020 | 25 | 0.730 |
Why?
|
| Peptidylprolyl Isomerase | 14 | 2002 | 19 | 0.720 |
Why?
|
| Protein Conformation | 12 | 2023 | 766 | 0.720 |
Why?
|
| Viral Load | 1 | 2021 | 228 | 0.710 |
Why?
|
| Viruses | 1 | 2021 | 79 | 0.710 |
Why?
|
| Amino Acid Sequence | 26 | 2015 | 1582 | 0.700 |
Why?
|
| HIV Integrase | 3 | 2011 | 9 | 0.700 |
Why?
|
| Membrane Proteins | 4 | 2021 | 843 | 0.700 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2020 | 8 | 0.690 |
Why?
|
| Interferon Type I | 4 | 2023 | 169 | 0.690 |
Why?
|
| HIV Seropositivity | 2 | 2020 | 82 | 0.680 |
Why?
|
| Cytoplasm | 5 | 2016 | 273 | 0.650 |
Why?
|
| Gammaretrovirus | 2 | 2019 | 7 | 0.650 |
Why?
|
| DNA, Viral | 10 | 2011 | 228 | 0.640 |
Why?
|
| Lentiviruses, Primate | 1 | 2018 | 2 | 0.630 |
Why?
|
| Transcription Factor AP-1 | 3 | 2015 | 41 | 0.630 |
Why?
|
| Betacoronavirus | 1 | 2020 | 159 | 0.620 |
Why?
|
| Ribonucleoproteins | 3 | 2023 | 112 | 0.580 |
Why?
|
| Cells, Cultured | 15 | 2021 | 2103 | 0.580 |
Why?
|
| Signal Transduction | 8 | 2021 | 2890 | 0.570 |
Why?
|
| Base Sequence | 18 | 2019 | 1312 | 0.560 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2020 | 255 | 0.550 |
Why?
|
| Viral Proteins | 6 | 2023 | 260 | 0.550 |
Why?
|
| Virus Internalization | 5 | 2023 | 97 | 0.550 |
Why?
|
| Cyclophilins | 5 | 2010 | 12 | 0.550 |
Why?
|
| Arsenicals | 3 | 2006 | 7 | 0.540 |
Why?
|
| Neutralization Tests | 4 | 2022 | 126 | 0.540 |
Why?
|
| Oxides | 3 | 2006 | 33 | 0.530 |
Why?
|
| Polyribosomes | 2 | 2021 | 14 | 0.520 |
Why?
|
| Nucleocapsid Proteins | 3 | 2020 | 34 | 0.520 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 4 | 2004 | 25 | 0.520 |
Why?
|
| Mass Screening | 1 | 2021 | 643 | 0.520 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2013 | 137 | 0.510 |
Why?
|
| Mice | 28 | 2023 | 10257 | 0.510 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2015 | 238 | 0.510 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2017 | 135 | 0.490 |
Why?
|
| Macaca mulatta | 8 | 2023 | 247 | 0.480 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2014 | 10 | 0.480 |
Why?
|
| RNA-Binding Proteins | 3 | 2014 | 384 | 0.470 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 2 | 2018 | 56 | 0.470 |
Why?
|
| Macrophages | 6 | 2020 | 1006 | 0.460 |
Why?
|
| T-Lymphocytes | 9 | 2015 | 963 | 0.450 |
Why?
|
| Transcription Factors | 8 | 2019 | 1456 | 0.430 |
Why?
|
| Membrane Glycoproteins | 6 | 2023 | 669 | 0.420 |
Why?
|
| Jurkat Cells | 12 | 2019 | 102 | 0.420 |
Why?
|
| Lentivirus | 6 | 2011 | 62 | 0.420 |
Why?
|
| DNA-Binding Proteins | 5 | 2021 | 1128 | 0.420 |
Why?
|
| Nucleocapsid | 3 | 2001 | 12 | 0.410 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2021 | 113 | 0.400 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2023 | 106 | 0.400 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2013 | 61 | 0.400 |
Why?
|
| Aotidae | 4 | 2009 | 9 | 0.400 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2024 | 416 | 0.400 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 375 | 0.400 |
Why?
|
| Retroviridae Infections | 3 | 2024 | 15 | 0.390 |
Why?
|
| Models, Molecular | 8 | 2020 | 1125 | 0.390 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 150 | 0.390 |
Why?
|
| Chromatography, Liquid | 3 | 2017 | 119 | 0.380 |
Why?
|
| Genome, Viral | 3 | 2022 | 121 | 0.380 |
Why?
|
| SAM Domain and HD Domain-Containing Protein 1 | 3 | 2018 | 4 | 0.380 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 135 | 0.370 |
Why?
|
| Proteasome Endopeptidase Complex | 5 | 2019 | 124 | 0.360 |
Why?
|
| Adenosine Triphosphatases | 1 | 2012 | 250 | 0.360 |
Why?
|
| Species Specificity | 6 | 2020 | 336 | 0.350 |
Why?
|
| Inflammation | 3 | 2022 | 1101 | 0.340 |
Why?
|
| Membrane Fusion | 5 | 2023 | 74 | 0.340 |
Why?
|
| Genes, gag | 6 | 2005 | 11 | 0.340 |
Why?
|
| Histones | 1 | 2012 | 463 | 0.330 |
Why?
|
| Chromatin | 4 | 2023 | 594 | 0.330 |
Why?
|
| Immunosuppressive Agents | 4 | 2021 | 293 | 0.330 |
Why?
|
| Proteomics | 3 | 2015 | 252 | 0.320 |
Why?
|
| Infectious Anemia Virus, Equine | 1 | 2009 | 2 | 0.320 |
Why?
|
| Gene Silencing | 4 | 2024 | 377 | 0.320 |
Why?
|
| Proline | 4 | 2004 | 39 | 0.320 |
Why?
|
| RNA Splicing | 4 | 2019 | 161 | 0.310 |
Why?
|
| Transfection | 10 | 2019 | 673 | 0.310 |
Why?
|
| Computational Biology | 1 | 2010 | 325 | 0.310 |
Why?
|
| Binding Sites | 9 | 2023 | 875 | 0.310 |
Why?
|
| G2 Phase | 5 | 2006 | 23 | 0.310 |
Why?
|
| RNA Interference | 7 | 2011 | 589 | 0.310 |
Why?
|
| Receptors, CCR5 | 2 | 2019 | 57 | 0.310 |
Why?
|
| HIV Protease | 4 | 2019 | 121 | 0.300 |
Why?
|
| Single-Cell Analysis | 2 | 2020 | 83 | 0.300 |
Why?
|
| Disease Outbreaks | 3 | 2023 | 105 | 0.300 |
Why?
|
| Antibodies, Monoclonal | 6 | 2020 | 870 | 0.290 |
Why?
|
| Amino Acid Substitution | 4 | 2016 | 253 | 0.290 |
Why?
|
| Cats | 4 | 2019 | 81 | 0.290 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 2009 | 255 | 0.290 |
Why?
|
| Transcription, Genetic | 5 | 2011 | 847 | 0.290 |
Why?
|
| Mutagenesis | 7 | 2002 | 129 | 0.290 |
Why?
|
| Protein Precursors | 5 | 1994 | 71 | 0.280 |
Why?
|
| Gene Editing | 2 | 2023 | 289 | 0.280 |
Why?
|
| Peptide Fragments | 4 | 2018 | 353 | 0.280 |
Why?
|
| HIV Core Protein p24 | 3 | 2016 | 17 | 0.280 |
Why?
|
| Primates | 3 | 2015 | 42 | 0.270 |
Why?
|
| HIV Antibodies | 3 | 2018 | 141 | 0.270 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2004 | 418 | 0.270 |
Why?
|
| Drug Resistance | 2 | 2005 | 97 | 0.270 |
Why?
|
| Nuclear Proteins | 5 | 2018 | 759 | 0.270 |
Why?
|
| Interleukin-2 | 2 | 2023 | 164 | 0.260 |
Why?
|
| DNA Transposable Elements | 2 | 2024 | 128 | 0.260 |
Why?
|
| Cold Temperature | 2 | 2023 | 51 | 0.260 |
Why?
|
| Algorithms | 4 | 2021 | 986 | 0.250 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2002 | 529 | 0.250 |
Why?
|
| Haplorhini | 1 | 2005 | 14 | 0.250 |
Why?
|
| Repressor Proteins | 3 | 2014 | 336 | 0.250 |
Why?
|
| Cell Line, Tumor | 7 | 2011 | 1370 | 0.250 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2005 | 75 | 0.250 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2023 | 324 | 0.250 |
Why?
|
| Endoplasmic Reticulum | 4 | 2010 | 167 | 0.250 |
Why?
|
| Evolution, Molecular | 4 | 2019 | 291 | 0.250 |
Why?
|
| SUMO-1 Protein | 1 | 2005 | 8 | 0.240 |
Why?
|
| Mutation | 11 | 2022 | 2427 | 0.240 |
Why?
|
| Drug Resistance, Viral | 1 | 2006 | 154 | 0.240 |
Why?
|
| Zinc Fingers | 2 | 2002 | 95 | 0.240 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 1537 | 0.240 |
Why?
|
| Karyopherins | 1 | 2024 | 7 | 0.240 |
Why?
|
| Proteome | 2 | 2015 | 135 | 0.240 |
Why?
|
| Phosphoproteins | 2 | 2018 | 216 | 0.240 |
Why?
|
| Antibodies, Neutralizing | 5 | 2022 | 192 | 0.240 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 307 | 0.230 |
Why?
|
| Phylogeny | 3 | 2021 | 331 | 0.230 |
Why?
|
| Retroelements | 1 | 2004 | 39 | 0.230 |
Why?
|
| Hemorrhagic Fevers, Viral | 1 | 2023 | 1 | 0.230 |
Why?
|
| In Vitro Techniques | 2 | 2020 | 475 | 0.230 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 3 | 2018 | 6 | 0.230 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2015 | 20 | 0.220 |
Why?
|
| RNA, Catalytic | 1 | 2003 | 18 | 0.220 |
Why?
|
| Vero Cells | 2 | 2020 | 75 | 0.220 |
Why?
|
| HIV Envelope Protein gp120 | 5 | 2018 | 139 | 0.220 |
Why?
|
| Centrosome | 1 | 2004 | 71 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 3 | 2013 | 193 | 0.220 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 288 | 0.220 |
Why?
|
| Carbon-Oxygen Lyases | 1 | 2003 | 2 | 0.220 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2023 | 17 | 0.210 |
Why?
|
| Phenotype | 7 | 2021 | 1156 | 0.210 |
Why?
|
| Fungal Proteins | 2 | 1995 | 142 | 0.210 |
Why?
|
| Zebrafish | 2 | 2023 | 323 | 0.210 |
Why?
|
| SAIDS Vaccines | 1 | 2022 | 23 | 0.210 |
Why?
|
| Monomeric GTP-Binding Proteins | 2 | 2014 | 39 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 278 | 0.210 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 33 | 0.200 |
Why?
|
| Chromosome Mapping | 3 | 2001 | 294 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 201 | 0.200 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2022 | 19 | 0.200 |
Why?
|
| Amphiregulin | 1 | 2022 | 4 | 0.200 |
Why?
|
| Proteolysis | 4 | 2019 | 138 | 0.200 |
Why?
|
| Mitosis | 1 | 2004 | 208 | 0.200 |
Why?
|
| AIDS Vaccines | 1 | 2022 | 67 | 0.200 |
Why?
|
| Genetic Fitness | 1 | 2022 | 31 | 0.200 |
Why?
|
| Software | 2 | 2015 | 367 | 0.200 |
Why?
|
| Amino Acids | 2 | 2020 | 140 | 0.200 |
Why?
|
| STAT1 Transcription Factor | 2 | 2012 | 35 | 0.200 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 42 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2021 | 367 | 0.190 |
Why?
|
| Virulence | 2 | 2016 | 189 | 0.190 |
Why?
|
| Colorado | 1 | 2021 | 19 | 0.190 |
Why?
|
| Disease | 1 | 2021 | 26 | 0.190 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2021 | 6 | 0.190 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 88 | 0.190 |
Why?
|
| Papillomavirus Vaccines | 1 | 2022 | 72 | 0.190 |
Why?
|
| 3' Untranslated Regions | 1 | 2021 | 84 | 0.190 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 42 | 0.190 |
Why?
|
| Cancer Vaccines | 1 | 2021 | 48 | 0.190 |
Why?
|
| Cell Cycle | 3 | 2004 | 379 | 0.180 |
Why?
|
| Point Mutation | 3 | 2019 | 162 | 0.180 |
Why?
|
| Biological Evolution | 1 | 2021 | 109 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 677 | 0.180 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2022 | 236 | 0.180 |
Why?
|
| Adipocytes, Beige | 1 | 2020 | 15 | 0.180 |
Why?
|
| Ubiquitin | 3 | 2011 | 95 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 40 | 0.180 |
Why?
|
| Plasmids | 5 | 2019 | 282 | 0.180 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 94 | 0.180 |
Why?
|
| RNA | 2 | 2021 | 404 | 0.180 |
Why?
|
| Colitis, Ulcerative | 1 | 2021 | 84 | 0.170 |
Why?
|
| Receptors, Virus | 1 | 2020 | 83 | 0.170 |
Why?
|
| Colon | 1 | 2021 | 137 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 169 | 0.170 |
Why?
|
| Virus Release | 1 | 2020 | 14 | 0.170 |
Why?
|
| Reverse Genetics | 1 | 2019 | 10 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 6 | 2012 | 663 | 0.170 |
Why?
|
| Phascolarctidae | 1 | 2019 | 3 | 0.170 |
Why?
|
| Interferon-beta | 2 | 2010 | 76 | 0.170 |
Why?
|
| Peptide Elongation Factors | 1 | 1999 | 4 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 157 | 0.170 |
Why?
|
| HIV Antigens | 1 | 1999 | 20 | 0.170 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 324 | 0.170 |
Why?
|
| Flavivirus Infections | 1 | 2019 | 4 | 0.170 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 71 | 0.170 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 221 | 0.160 |
Why?
|
| Mice, Knockout | 4 | 2021 | 1988 | 0.160 |
Why?
|
| CRISPR-Cas Systems | 2 | 2023 | 325 | 0.160 |
Why?
|
| Viral Matrix Proteins | 1 | 1999 | 51 | 0.160 |
Why?
|
| Thermogenesis | 1 | 2020 | 108 | 0.160 |
Why?
|
| Homozygote | 1 | 2019 | 117 | 0.160 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 7 | 0.160 |
Why?
|
| DNA | 3 | 2003 | 793 | 0.160 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2011 | 28 | 0.160 |
Why?
|
| Liver Transplantation | 1 | 2021 | 189 | 0.160 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2018 | 47 | 0.160 |
Why?
|
| Cullin Proteins | 1 | 2018 | 9 | 0.160 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 78 | 0.160 |
Why?
|
| Sequence Deletion | 3 | 2014 | 114 | 0.160 |
Why?
|
| Cyclosporins | 2 | 1996 | 7 | 0.160 |
Why?
|
| Endonucleases | 1 | 2019 | 81 | 0.160 |
Why?
|
| Referral and Consultation | 1 | 2022 | 409 | 0.150 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2011 | 23 | 0.150 |
Why?
|
| Male | 8 | 2022 | 27509 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 643 | 0.150 |
Why?
|
| Gene Expression | 5 | 2018 | 808 | 0.150 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 134 | 0.150 |
Why?
|
| Two-Hybrid System Techniques | 4 | 2011 | 65 | 0.150 |
Why?
|
| Immunologic Memory | 1 | 2020 | 276 | 0.150 |
Why?
|
| Melanoma | 1 | 2021 | 334 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 186 | 0.140 |
Why?
|
| Homeostasis | 1 | 2020 | 340 | 0.140 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 101 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 198 | 0.140 |
Why?
|
| Viral Tropism | 1 | 2018 | 55 | 0.140 |
Why?
|
| Mass Spectrometry | 3 | 2015 | 285 | 0.140 |
Why?
|
| Cell Line, Transformed | 4 | 2010 | 97 | 0.140 |
Why?
|
| CD4 Antigens | 1 | 2018 | 155 | 0.140 |
Why?
|
| Africa, Western | 1 | 2016 | 5 | 0.140 |
Why?
|
| Cheirogaleidae | 1 | 2016 | 6 | 0.140 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2016 | 21 | 0.140 |
Why?
|
| Callithrix | 1 | 2016 | 19 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 220 | 0.140 |
Why?
|
| Molecular Chaperones | 2 | 2009 | 97 | 0.140 |
Why?
|
| Retroviridae Proteins | 1 | 2016 | 3 | 0.140 |
Why?
|
| DNA Primers | 3 | 2005 | 291 | 0.130 |
Why?
|
| Chromosome Banding | 1 | 1996 | 10 | 0.130 |
Why?
|
| Islets of Langerhans | 2 | 2016 | 267 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1996 | 13 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 3189 | 0.130 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 254 | 0.130 |
Why?
|
| CDC2 Protein Kinase | 1 | 1995 | 33 | 0.130 |
Why?
|
| Cyclins | 1 | 1995 | 40 | 0.130 |
Why?
|
| Pandemics | 1 | 2020 | 606 | 0.130 |
Why?
|
| Analytic Sample Preparation Methods | 1 | 2015 | 4 | 0.130 |
Why?
|
| Gene Products, env | 3 | 2019 | 21 | 0.120 |
Why?
|
| Spleen | 4 | 2005 | 485 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 152 | 0.120 |
Why?
|
| Genomics | 1 | 2018 | 314 | 0.120 |
Why?
|
| Mason-Pfizer monkey virus | 1 | 2014 | 2 | 0.120 |
Why?
|
| Female | 7 | 2022 | 30827 | 0.120 |
Why?
|
| NF-kappa B | 3 | 2012 | 461 | 0.120 |
Why?
|
| Rats | 3 | 2016 | 1907 | 0.120 |
Why?
|
| Child | 2 | 2022 | 4300 | 0.110 |
Why?
|
| Glycoproteins | 3 | 2023 | 193 | 0.110 |
Why?
|
| Enzyme Activation | 2 | 2011 | 353 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 5 | 1998 | 454 | 0.110 |
Why?
|
| Genetic Techniques | 4 | 1995 | 40 | 0.110 |
Why?
|
| Genome | 2 | 2019 | 253 | 0.110 |
Why?
|
| Typhoid Fever | 1 | 2013 | 21 | 0.110 |
Why?
|
| Salmonella typhi | 1 | 2013 | 19 | 0.110 |
Why?
|
| Gene Products, vif | 2 | 2007 | 9 | 0.110 |
Why?
|
| Virus Uncoating | 1 | 2013 | 2 | 0.110 |
Why?
|
| Virology | 1 | 2013 | 13 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2023 | 427 | 0.110 |
Why?
|
| Transcriptome | 1 | 2016 | 324 | 0.110 |
Why?
|
| Antigens, CD | 3 | 2009 | 343 | 0.110 |
Why?
|
| Interferon-alpha | 2 | 2010 | 99 | 0.110 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2020 | 72 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2003 | 357 | 0.110 |
Why?
|
| Terminal Repeat Sequences | 1 | 2012 | 13 | 0.110 |
Why?
|
| Nanog Homeobox Protein | 1 | 2012 | 10 | 0.110 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2012 | 16 | 0.110 |
Why?
|
| Valosin Containing Protein | 1 | 2012 | 4 | 0.110 |
Why?
|
| Mammals | 3 | 2023 | 204 | 0.100 |
Why?
|
| Reassortant Viruses | 1 | 2012 | 9 | 0.100 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2012 | 20 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 3 | 2019 | 231 | 0.100 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2012 | 6 | 0.100 |
Why?
|
| Vesiculovirus | 1 | 2012 | 10 | 0.100 |
Why?
|
| Exodeoxyribonucleases | 1 | 2012 | 28 | 0.100 |
Why?
|
| Moloney murine leukemia virus | 1 | 1992 | 5 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 219 | 0.100 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2013 | 90 | 0.100 |
Why?
|
| Dimerization | 2 | 2005 | 146 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2012 | 179 | 0.100 |
Why?
|
| Herpesvirus 4, Human | 1 | 2013 | 181 | 0.100 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2011 | 12 | 0.100 |
Why?
|
| Peptides | 1 | 2015 | 548 | 0.100 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2011 | 22 | 0.100 |
Why?
|
| HIV Reverse Transcriptase | 2 | 2005 | 9 | 0.100 |
Why?
|
| Exons | 2 | 2004 | 193 | 0.100 |
Why?
|
| Nuclear Envelope | 1 | 2011 | 46 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2062 | 0.090 |
Why?
|
| Peptide Elongation Factor 1 | 2 | 2002 | 4 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 276 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2005 | 944 | 0.090 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2011 | 31 | 0.090 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 23 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 74 | 0.090 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2010 | 18 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2010 | 121 | 0.090 |
Why?
|
| Apoptosis Inducing Factor | 2 | 2007 | 5 | 0.090 |
Why?
|
| Gene Deletion | 2 | 2005 | 298 | 0.090 |
Why?
|
| Databases, Genetic | 1 | 2010 | 82 | 0.090 |
Why?
|
| Protein Domains | 2 | 2022 | 141 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2010 | 250 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 145 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 403 | 0.080 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2009 | 5 | 0.080 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Polyproteins | 1 | 2009 | 8 | 0.080 |
Why?
|
| CpG Islands | 1 | 2010 | 212 | 0.080 |
Why?
|
| Apoptosis | 3 | 2021 | 1038 | 0.080 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 112 | 0.080 |
Why?
|
| Cell Division | 3 | 2004 | 442 | 0.080 |
Why?
|
| Vaccinia | 1 | 2009 | 31 | 0.080 |
Why?
|
| Crystallography, X-Ray | 2 | 2023 | 422 | 0.080 |
Why?
|
| Plasma Cells | 1 | 2009 | 48 | 0.080 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 145 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 396 | 0.080 |
Why?
|
| Endosomes | 2 | 2023 | 170 | 0.080 |
Why?
|
| Vaccinia virus | 1 | 2009 | 71 | 0.080 |
Why?
|
| Protein Engineering | 1 | 2009 | 77 | 0.080 |
Why?
|
| Tacrolimus | 2 | 2021 | 39 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 646 | 0.080 |
Why?
|
| Cell Survival | 2 | 2001 | 553 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1470 | 0.080 |
Why?
|
| Gene Transfer Techniques | 2 | 2008 | 304 | 0.080 |
Why?
|
| Calcium | 2 | 2023 | 555 | 0.080 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2009 | 93 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2011 | 617 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2008 | 92 | 0.070 |
Why?
|
| Receptors, Immunologic | 2 | 2009 | 178 | 0.070 |
Why?
|
| Hepacivirus | 1 | 2009 | 140 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2009 | 179 | 0.070 |
Why?
|
| Flow Cytometry | 4 | 2018 | 671 | 0.070 |
Why?
|
| Minor Histocompatibility Antigens | 3 | 2014 | 34 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 645 | 0.070 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2007 | 8 | 0.070 |
Why?
|
| Biomarkers | 1 | 2012 | 1205 | 0.070 |
Why?
|
| Gene Products, pol | 2 | 2019 | 9 | 0.070 |
Why?
|
| Kinetics | 3 | 2000 | 733 | 0.070 |
Why?
|
| Time Factors | 5 | 2008 | 3567 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 1 | 2007 | 101 | 0.070 |
Why?
|
| Lysine | 1 | 2007 | 75 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2000 | 500 | 0.070 |
Why?
|
| Genes, vpr | 2 | 1997 | 4 | 0.070 |
Why?
|
| Trypsin | 2 | 2017 | 41 | 0.070 |
Why?
|
| Tropism | 1 | 2006 | 17 | 0.070 |
Why?
|
| Ions | 2 | 2017 | 52 | 0.070 |
Why?
|
| Aotus trivirgatus | 1 | 2006 | 1 | 0.070 |
Why?
|
| Stem Cells | 1 | 2008 | 257 | 0.070 |
Why?
|
| Muromonab-CD3 | 1 | 2005 | 7 | 0.060 |
Why?
|
| Models, Biological | 4 | 2008 | 1139 | 0.060 |
Why?
|
| Protein Sorting Signals | 2 | 1997 | 57 | 0.060 |
Why?
|
| Ubiquitination | 2 | 2019 | 106 | 0.060 |
Why?
|
| Primary Cell Culture | 2 | 2015 | 75 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2005 | 69 | 0.060 |
Why?
|
| Sarcoma, Experimental | 1 | 2005 | 6 | 0.060 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2005 | 7 | 0.060 |
Why?
|
| Calcineurin Inhibitors | 1 | 2005 | 22 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 506 | 0.060 |
Why?
|
| Tumor Virus Infections | 1 | 2005 | 38 | 0.060 |
Why?
|
| Calcineurin | 1 | 2005 | 42 | 0.060 |
Why?
|
| Spiro Compounds | 1 | 2004 | 12 | 0.060 |
Why?
|
| Lactones | 1 | 2004 | 25 | 0.060 |
Why?
|
| Co-Repressor Proteins | 1 | 2005 | 22 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2012 | 290 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2004 | 32 | 0.060 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2004 | 17 | 0.060 |
Why?
|
| Monocytes | 3 | 2015 | 351 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2020 | 363 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2005 | 176 | 0.060 |
Why?
|
| Umbilical Veins | 1 | 2004 | 14 | 0.060 |
Why?
|
| Th2 Cells | 1 | 2004 | 98 | 0.060 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2004 | 24 | 0.060 |
Why?
|
| Flavoproteins | 1 | 2004 | 29 | 0.060 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2018 | 83 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2006 | 367 | 0.060 |
Why?
|
| Hypersensitivity | 1 | 2004 | 60 | 0.060 |
Why?
|
| Gene Library | 2 | 2016 | 99 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 376 | 0.060 |
Why?
|
| Cold-Shock Response | 1 | 2023 | 3 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 2 | 1994 | 92 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 2018 | 695 | 0.060 |
Why?
|
| Interleukin-15 | 1 | 2023 | 21 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 201 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2000 | 659 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2004 | 222 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2003 | 53 | 0.050 |
Why?
|
| Nuclear Pore | 1 | 2023 | 22 | 0.050 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2023 | 26 | 0.050 |
Why?
|
| Detergents | 1 | 2023 | 35 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 880 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 1093 | 0.050 |
Why?
|
| Spindle Apparatus | 1 | 2004 | 123 | 0.050 |
Why?
|
| Antigens | 1 | 2023 | 146 | 0.050 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 5 | 0.050 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2022 | 6 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2003 | 87 | 0.050 |
Why?
|
| Convalescence | 1 | 2022 | 17 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 1994 | 102 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 165 | 0.050 |
Why?
|
| Contact Tracing | 1 | 2022 | 15 | 0.050 |
Why?
|
| Schizosaccharomyces | 1 | 2004 | 106 | 0.050 |
Why?
|
| Myxovirus Resistance Proteins | 2 | 2014 | 5 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2023 | 179 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2022 | 43 | 0.050 |
Why?
|
| Seasons | 1 | 2023 | 129 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2005 | 607 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1221 | 0.050 |
Why?
|
| Glycosaminoglycans | 1 | 2002 | 18 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 162 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 108 | 0.050 |
Why?
|
| Protein Subunits | 2 | 2014 | 164 | 0.050 |
Why?
|
| Neurons | 1 | 2007 | 858 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1549 | 0.050 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2001 | 53 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2023 | 175 | 0.050 |
Why?
|
| Universities | 1 | 2022 | 152 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 72 | 0.050 |
Why?
|
| Mitochondria | 1 | 2004 | 333 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2021 | 32 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2022 | 485 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2021 | 861 | 0.050 |
Why?
|
| Epidemiological Monitoring | 1 | 2020 | 25 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 304 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2021 | 243 | 0.050 |
Why?
|
| Muridae | 1 | 2000 | 8 | 0.050 |
Why?
|
| Pseudogenes | 1 | 2000 | 16 | 0.050 |
Why?
|
| Centrifugation, Isopycnic | 1 | 2000 | 2 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 118 | 0.050 |
Why?
|
| DNA Probes | 1 | 2000 | 35 | 0.050 |
Why?
|
| Neuregulins | 1 | 2020 | 8 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2001 | 82 | 0.040 |
Why?
|
| Genes, Essential | 1 | 2000 | 18 | 0.040 |
Why?
|
| Denervation | 1 | 2020 | 17 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 116 | 0.040 |
Why?
|
| Fatty Acid Synthases | 1 | 2020 | 22 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 141 | 0.040 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 47 | 0.040 |
Why?
|
| Genes | 1 | 2000 | 96 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 183 | 0.040 |
Why?
|
| Luciferases | 1 | 2000 | 109 | 0.040 |
Why?
|
| Interferons | 2 | 2012 | 64 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 425 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2020 | 110 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2020 | 82 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 35 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 119 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2020 | 143 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2020 | 69 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 236 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2015 | 492 | 0.040 |
Why?
|
| United States | 2 | 2023 | 7494 | 0.040 |
Why?
|
| Subtilisins | 1 | 1999 | 2 | 0.040 |
Why?
|
| GPI-Linked Proteins | 2 | 2009 | 35 | 0.040 |
Why?
|
| Boston | 1 | 2020 | 329 | 0.040 |
Why?
|
| RNA, Antisense | 1 | 2019 | 48 | 0.040 |
Why?
|
| Flavivirus | 1 | 2019 | 8 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2019 | 15 | 0.040 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1999 | 11 | 0.040 |
Why?
|
| Nuclear Localization Signals | 1 | 2019 | 18 | 0.040 |
Why?
|
| Genetic Code | 1 | 2019 | 7 | 0.040 |
Why?
|
| Inverted Repeat Sequences | 1 | 2019 | 14 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 58 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2020 | 100 | 0.040 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 74 | 0.040 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 1999 | 36 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 462 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 85 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 397 | 0.040 |
Why?
|
| Chromosomes | 1 | 2000 | 133 | 0.040 |
Why?
|
| Germ Cells | 1 | 2019 | 97 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2019 | 68 | 0.040 |
Why?
|
| Blotting, Western | 3 | 2010 | 595 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2019 | 170 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 330 | 0.040 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 1998 | 12 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 1999 | 76 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2020 | 144 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 484 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 681 | 0.040 |
Why?
|
| Alanine | 1 | 1998 | 46 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2019 | 321 | 0.040 |
Why?
|
| Sf9 Cells | 1 | 2018 | 6 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 16238 | 0.040 |
Why?
|
| Papio | 1 | 1998 | 13 | 0.040 |
Why?
|
| Young Adult | 2 | 2021 | 4320 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1527 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 150 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 281 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 1998 | 98 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 171 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 515 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 5917 | 0.040 |
Why?
|
| Epitopes | 3 | 1995 | 298 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 293 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2018 | 167 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 177 | 0.030 |
Why?
|
| Pan troglodytes | 1 | 1996 | 35 | 0.030 |
Why?
|
| Aminocoumarins | 1 | 2016 | 1 | 0.030 |
Why?
|
| Microfluidics | 1 | 2016 | 21 | 0.030 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 160 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2014 | 2437 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 419 | 0.030 |
Why?
|
| Host Specificity | 1 | 2015 | 6 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2018 | 434 | 0.030 |
Why?
|
| Gene Products, nef | 1 | 2015 | 14 | 0.030 |
Why?
|
| Chaperonins | 1 | 1995 | 8 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 338 | 0.030 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2015 | 5 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 451 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2010 | 740 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 1 | 1995 | 49 | 0.030 |
Why?
|
| Radioimmunoprecipitation Assay | 1 | 2015 | 2 | 0.030 |
Why?
|
| Trichloroacetic Acid | 1 | 2015 | 3 | 0.030 |
Why?
|
| Acetone | 1 | 2015 | 3 | 0.030 |
Why?
|
| Adult | 3 | 2021 | 15735 | 0.030 |
Why?
|
| Octoxynol | 1 | 2015 | 12 | 0.030 |
Why?
|
| Buffers | 1 | 2015 | 19 | 0.030 |
Why?
|
| Chemical Precipitation | 1 | 2015 | 11 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1996 | 155 | 0.030 |
Why?
|
| RNA Probes | 2 | 1993 | 9 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1994 | 385 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2015 | 65 | 0.030 |
Why?
|
| False Positive Reactions | 1 | 1995 | 74 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2015 | 79 | 0.030 |
Why?
|
| Solubility | 1 | 2015 | 173 | 0.030 |
Why?
|
| Biotechnology | 1 | 1995 | 42 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 351 | 0.030 |
Why?
|
| Retinoblastoma Protein | 1 | 1994 | 37 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 810 | 0.030 |
Why?
|
| Benchmarking | 1 | 2015 | 135 | 0.030 |
Why?
|
| Ribonucleases | 1 | 1994 | 31 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1995 | 454 | 0.030 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1995 | 57 | 0.030 |
Why?
|
| Methionine | 1 | 1994 | 56 | 0.030 |
Why?
|
| Viral Core Proteins | 1 | 1993 | 30 | 0.030 |
Why?
|
| Viral Structural Proteins | 1 | 1993 | 16 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 394 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 837 | 0.030 |
Why?
|
| Uridine | 1 | 2013 | 16 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2009 | 1295 | 0.030 |
Why?
|
| Histidine | 1 | 1993 | 31 | 0.030 |
Why?
|
| Lymphoid Tissue | 2 | 1983 | 55 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 243 | 0.030 |
Why?
|
| Cysteine | 1 | 1993 | 107 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 439 | 0.030 |
Why?
|
| Japan | 1 | 2012 | 60 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 195 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2013 | 124 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1992 | 81 | 0.020 |
Why?
|
| Genes, nef | 1 | 2011 | 6 | 0.020 |
Why?
|
| Genes, env | 1 | 2011 | 15 | 0.020 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2011 | 25 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2011 | 45 | 0.020 |
Why?
|
| Micropore Filters | 1 | 1991 | 1 | 0.020 |
Why?
|
| Collodion | 1 | 1991 | 3 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5067 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 1991 | 15 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 71 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2008 | 813 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1991 | 138 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 174 | 0.020 |
Why?
|
| Sequestosome-1 Protein | 1 | 2010 | 8 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 80 | 0.020 |
Why?
|
| Temperature | 1 | 1991 | 300 | 0.020 |
Why?
|
| Polyubiquitin | 1 | 2009 | 8 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2009 | 31 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 35 | 0.020 |
Why?
|
| APOBEC-3G Deaminase | 1 | 2009 | 21 | 0.020 |
Why?
|
| DEAD Box Protein 58 | 1 | 2009 | 18 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2009 | 48 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 306 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2009 | 65 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 525 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 190 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 66 | 0.020 |
Why?
|
| Protein Folding | 1 | 2010 | 256 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2009 | 108 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2009 | 77 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2009 | 81 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2008 | 13 | 0.020 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 66 | 0.020 |
Why?
|
| Lectins | 1 | 2008 | 38 | 0.020 |
Why?
|
| HIV | 1 | 2008 | 69 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 188 | 0.020 |
Why?
|
| Genistein | 1 | 2006 | 9 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 550 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1991 | 685 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2006 | 60 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2005 | 49 | 0.020 |
Why?
|
| Transplantation | 1 | 2005 | 6 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2005 | 65 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 13293 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2007 | 280 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 140 | 0.020 |
Why?
|
| Transplantation Tolerance | 1 | 2005 | 65 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2005 | 118 | 0.020 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2004 | 19 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2004 | 9 | 0.010 |
Why?
|
| Vimentin | 1 | 2004 | 18 | 0.010 |
Why?
|
| Staurosporine | 1 | 2004 | 19 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 129 | 0.010 |
Why?
|
| Surface Plasmon Resonance | 1 | 2003 | 33 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 148 | 0.010 |
Why?
|
| Phagocytes | 1 | 1983 | 49 | 0.010 |
Why?
|
| Disulfides | 1 | 2003 | 62 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 2003 | 54 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 422 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 353 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 191 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 377 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 1488 | 0.010 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1994 | 8 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1993 | 32 | 0.010 |
Why?
|
| Carcinoma | 1 | 1994 | 117 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 182 | 0.010 |
Why?
|
| Cell Separation | 2 | 1983 | 149 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1983 | 219 | 0.010 |
Why?
|
| DNA Helicases | 1 | 1994 | 187 | 0.010 |
Why?
|
| Movement | 1 | 1993 | 146 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1983 | 32 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1983 | 48 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1983 | 99 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1983 | 59 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1983 | 211 | 0.000 |
Why?
|
| Skin | 1 | 1983 | 351 | 0.000 |
Why?
|